Targeting type-2 metabotropic glutamate receptors to protect vulnerable hippocampal neurons against ischemic damage
暂无分享,去创建一个
F. Nicoletti | G. Battaglia | V. Bruno | S. Poli | Sylvain Celanire | R. Lütjens | B. Riozzi | M. Motolese | F. Mastroiacovo | M. Cannella | D. Bucci | A. Gaglione | Marta Motolese
[1] S. Gatti,et al. Novel metabotropic glutamate receptor 2/3 antagonists and their therapeutic applications: a patent review (2005 – present) , 2015, Expert opinion on therapeutic patents.
[2] B. Mcewen,et al. Mind the gap: glucocorticoids modulate hippocampal glutamate tone underlying individual differences in stress susceptibility , 2014, Molecular Psychiatry.
[3] W. Drinkenburg,et al. Blockade of the metabotropic glutamate (mGluR2) modulates arousal through vigilance states transitions: Evidence from sleep–wake EEG in rodents , 2014, Behavioural Brain Research.
[4] S. Chiechio,et al. HDAC and HAT inhibitors differently affect analgesia mediated by group II metabotropic glutamate receptors , 2014, Molecular pain.
[5] D. Lovinger,et al. Loss of metabotropic glutamate receptor 2 escalates alcohol consumption , 2013, Proceedings of the National Academy of Sciences.
[6] J. Witkin,et al. mGlu2/3 agonist-induced hyperthermia: an in vivo assay for detection of mGlu2/3 receptor antagonism and its relation to antidepressant-like efficacy in mice. , 2013, CNS & neurological disorders drug targets.
[7] T. Salt,et al. ADX71743, a Potent and Selective Negative Allosteric Modulator of Metabotropic Glutamate Receptor 7: In Vitro and In Vivo Characterization , 2013, The Journal of Pharmacology and Experimental Therapeutics.
[8] F. Nicoletti,et al. L-acetylcarnitine causes rapid antidepressant effects through the epigenetic induction of mGlu2 receptors , 2013, Proceedings of the National Academy of Sciences.
[9] D. Umbricht,et al. Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target , 2013, Neuropharmacology.
[10] Scott J. Russo,et al. HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity , 2012, Nature Neuroscience.
[11] B. Luo,et al. Inhibition of P2X7 receptor ameliorates transient global cerebral ischemia/reperfusion injury via modulating inflammatory responses in the rat hippocampus , 2012, Journal of Neuroinflammation.
[12] A. Guidotti,et al. Pharmacological Activation of Group-II Metabotropic Glutamate Receptors Corrects a Schizophrenia-Like Phenotype Induced by Prenatal Stress in Mice , 2012, Neuropsychopharmacology.
[13] S. Haggarty,et al. An epigenetic blockade of cognitive functions in the neurodegenerating brain , 2012, Nature.
[14] J. Wierońska,et al. On the mechanism of anti-hyperthermic effects of LY379268 and LY487379, group II mGlu receptors activators, in the stress-induced hyperthermia in singly housed mice , 2012, Neuropharmacology.
[15] A. Klein-Szanto,et al. Thymine DNA Glycosylase Is Essential for Active DNA Demethylation by Linked Deamination-Base Excision Repair , 2011, Cell.
[16] F. Nicoletti,et al. Metabotropic glutamate receptors: From the workbench to the bedside , 2011, Neuropharmacology.
[17] G. Collingridge,et al. Study of Novel Selective mGlu2 Agonist in the Temporo-Ammonic Input to CA1 Neurons Reveals Reduced mGlu2 Receptor Expression in a Wistar Substrain with an Anxiety-Like Phenotype , 2011, The Journal of Neuroscience.
[18] E. Nisenbaum,et al. Targeting Group II Metabotropic Glutamate (mGlu) Receptors for the Treatment of Psychosis Associated with Alzheimer's Disease: Selective Activation of mGlu2 Receptors Amplifies β-Amyloid Toxicity in Cultured Neurons, Whereas Dual Activation of mGlu2 and mGlu3 Receptors Is Neuroprotective , 2011, Molecular Pharmacology.
[19] F. Nicoletti,et al. Epigenetic Modulation of mGlu2 Receptors by Histone Deacetylase Inhibitors in the Treatment of Inflammatory Pain , 2009, Molecular Pharmacology.
[20] B. Cairns,et al. DNA Demethylation in Zebrafish Involves the Coupling of a Deaminase, a Glycosylase, and Gadd45 , 2008, Cell.
[21] V. Kaushal,et al. Mechanisms of Microglia-Mediated Neurotoxicity in a New Model of the Stroke Penumbra , 2008, The Journal of Neuroscience.
[22] J. Kalbfleisch,et al. Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion , 2007, Journal of Neuroimmunology.
[23] F. Nicoletti,et al. The Use of Knock-Out Mice Unravels Distinct Roles for mGlu2 and mGlu3 Metabotropic Glutamate Receptors in Mechanisms of Neurodegeneration/Neuroprotection , 2007, The Journal of Neuroscience.
[24] Q. Pittman,et al. Peripheral Inflammation Exacerbates Damage After Global Ischemia Independently of Temperature and Acute Brain Inflammation , 2007, Stroke.
[25] Christof Niehrs,et al. Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation , 2007, Nature.
[26] S. Chaki,et al. Effects of metabotropic glutamate 2/3 receptor antagonists in the stress-induced hyperthermia test in singly housed mice , 2006, Psychopharmacology.
[27] T. Yeh,et al. Global ischemia downregulates the function of metabotropic glutamate receptor subtype 5 in hippocampal CA1 pyramidal neurons , 2005, Molecular and Cellular Neuroscience.
[28] Deanna L. Taylor,et al. Stimulation of Microglial Metabotropic Glutamate Receptor mGlu2 Triggers Tumor Necrosis Factor α-Induced Neurotoxicity in Concert with Microglial-Derived Fas Ligand , 2005, The Journal of Neuroscience.
[29] G. Gaviraghi,et al. Induction of Dickkopf-1, a Negative Modulator of the Wnt Pathway, Is Required for the Development of Ischemic Neuronal Death , 2005, The Journal of Neuroscience.
[30] M. Bennett,et al. Late Calcium EDTA Rescues Hippocampal CA1 Neurons from Global Ischemia-Induced Death , 2004, The Journal of Neuroscience.
[31] L. Bristow,et al. Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2. , 2003, Molecular pharmacology.
[32] J. Geurts,et al. Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis. , 2003, Brain : a journal of neurology.
[33] D. Schoepp,et al. Discovery of allosteric potentiators for the metabotropic glutamate 2 receptor: synthesis and subtype selectivity of N-(4-(2-methoxyphenoxy)phenyl)-N-(2,2,2- trifluoroethylsulfonyl)pyrid-3-ylmethylamine. , 2003, Journal of medicinal chemistry.
[34] M. Bennett,et al. Ischemic Insults Derepress the Gene Silencer REST in Neurons Destined to Die , 2003, The Journal of Neuroscience.
[35] E. Meli,et al. Activation of mGlu1 but not mGlu5 metabotropic glutamate receptors contributes to postischemic neuronal injury in vitro and in vivo , 2002, Pharmacology Biochemistry and Behavior.
[36] M. Cuzner,et al. Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up‐regulated in Alzheimer's disease , 2002, Journal of neurochemistry.
[37] F. Nicoletti,et al. Metabotropic Glutamate Receptor Subtypes as Targets for Neuroprotective Drugs , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[38] P. Ornstein,et al. [3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain. , 2001, The Journal of pharmacology and experimental therapeutics.
[39] B. Gähwiler,et al. Differential control of GABA release at synapses from distinct interneurons in rat hippocampus , 2000, The Journal of physiology.
[40] M. O'Neill,et al. LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia , 1999, Neuroscience Letters.
[41] E. Meli,et al. 1‐Aminoindan‐1,5‐dicarboxylic acid and (S)‐(+)‐2‐(3′‐carboxybicyclo[1.1.1] pentyl)‐glycine, two mGlu1 receptor‐preferring antagonists, reduce neuronal death in in vitro and in vivo models of cerebral ischaemia , 1999, The European journal of neuroscience.
[42] E. Meli,et al. Protection with metabotropic glutamate 1 receptor antagonists in models of ischemic neuronal death: time-course and mechanisms , 1999, Neuropharmacology.
[43] P. Chan,et al. Expression of cyclooxygenase-2 mRNA after global ischemia is regulated by AMPA receptors and glucocorticoids. , 1999, Stroke.
[44] A. Buchan,et al. Continuing postischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats. , 1999, Stroke.
[45] R. Simon,et al. Transient Global Ischemia Triggers Expression of the DNA Damage-Inducible Gene GADD45 in the Rat Brain , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[46] M. O'Neill,et al. Neuroprotective effects of a systemically active Group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia , 1998, Neuroreport.
[47] M. Bennett,et al. The GluR2 (GluR-B) hypothesis: Ca2+-permeable AMPA receptors in neurological disorders , 1997, Trends in Neurosciences.
[48] S. Yatsugi,et al. Neuroprotective effect of YM90K, an AMPA-receptor antagonist, against delayed neuronal death induced by transient global cerebral ischemia in gerbils and rats. , 1997, Japanese journal of pharmacology.
[49] D. Stephenson,et al. Global Ischemia Activates Nuclear Factor-κB in Forebrain Neurons of Rats , 1997 .
[50] R. Miles,et al. Dual modulation of synaptic inhibition by distinct metabotropic glutamate receptors in the rat hippocampus. , 1995, The Journal of physiology.
[51] E. Mulvihill,et al. Changes in Metabotropic Glutamate Receptor mRNA Levels Following Global Ischemia: Increase of a Putative Presynaptic Subtype (mGluR4) in Highly Vulnerable Rat Brain Areas , 1994, Journal of neurochemistry.
[52] N. Diemer,et al. Changes in mRNA for metabotropic glutamate receptors after transient cerebral ischaemia. , 1994, Neuroreport.
[53] M. Bennett,et al. Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[54] R. Schmidt-Kastner,et al. Selective vulnerability of the hippocampus in brain ischemia , 1991, Neuroscience.
[55] A. Buchan,et al. Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats , 1991, Neuroscience Letters.
[56] J. Brierley,et al. A New Model of Bilateral Hemispheric Ischemia in the Unanesthetized Rat , 1979, Stroke.
[57] D. Stephenson,et al. Global ischemia activates nuclear factor-kappa B in forebrain neurons of rats. , 1997, Stroke.